abrdn Healthcare director buys 501 HQH shares

Q: What insider transaction did abrdn Healthcare Investors (HQH) report in this Form 4?

abrdn Healthcare Investors reported that director Chris LaVictoire Mahai bought 501 shares of Common Stock. The purchase occurred on July 16, 2026 as an open-market or private transaction, according to the transaction code description in the filing.

Q: How many HQH shares did the director buy and at what price?

Director Chris LaVictoire Mahai purchased 501.0000 shares of HQH Common Stock at $20.9600 per share. This was recorded as a non-derivative, open-market or private transaction, reflecting a straightforward equity purchase rather than an option exercise or derivative conversion.

Q: Was the July 16, 2026 HQH stock purchase made under a Rule 10b5-1 trading plan?

The filing’s Rule 10b5-1 checkbox is unchecked, indicating the July 16, 2026 purchase was not made under a Rule 10b5-1 trading plan. No footnotes in the reported data suggest any pre-arranged trading arrangement for this specific transaction.

Q: What transaction code and type are shown for the HQH insider trade?

The transaction is coded “P”, described as a “Purchase in open market or private transaction.” It is categorized as a non-derivative transaction in Common Stock, distinguishing it from option exercises, conversions, or other derivative-related activities sometimes seen in Form 4 filings.

abrdn Healthcare Investors director Chris LaVictoire Mahai purchased 501 shares of Common Stock at $20.9600 per share on July 16, 2026.

Accepted by SEC EDGAR 07/20/2026 - 02:34 PM EDT

Filing Impact

(Moderate)

Filing Sentiment

(Positive)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

abrdn Healthcare Investors director Chris LaVictoire Mahai purchased 501 shares of Common Stock at $20.9600 per share on July 16, 2026. After this open-market transaction, the director directly owns 501.0000 shares of HQH. The filing indicates the trade was not made under a Rule 10b5-1 plan.

Insider Trade Summary

Net Buyer: 501 shares

Net Buy 1 txn

Insider Mahai Chris LaVictoire

Role Director

Bought 501 shs ($11K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	501	$20.96	$11K

Holdings After Transaction: Common Stock — 501 shares (Direct)

Key Figures

Shares purchased: 501.0000 shares Purchase price: $20.9600 per share Shares owned after transaction: 501.0000 shares +1 more

4 metrics

Shares purchased 501.0000 shares Common Stock bought on July 16, 2026

Purchase price $20.9600 per share Price paid for HQH Common Stock in the reported transaction

Shares owned after transaction 501.0000 shares Director’s direct holdings following the July 16, 2026 purchase

Net shares bought 501 shares Net buy activity in the transaction summary (net-buy direction)

Key Terms

Common Stock, Purchase in open market or private transaction, direct ownership

3 terms

Common Stock financial

"security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Purchase in open market or private transaction financial

"transaction_code_description: "Purchase in open market or private transaction""

direct ownership financial

"ownership_type: "direct" with ownership_code "D""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did abrdn Healthcare Investors (HQH) report in this Form 4?

abrdn Healthcare Investors reported that director Chris LaVictoire Mahai bought 501 shares of Common Stock. The purchase occurred on July 16, 2026 as an open-market or private transaction, according to the transaction code description in the filing.

How many HQH shares did the director buy and at what price?

Director Chris LaVictoire Mahai purchased 501.0000 shares of HQH Common Stock at $20.9600 per share. This was recorded as a non-derivative, open-market or private transaction, reflecting a straightforward equity purchase rather than an option exercise or derivative conversion.

What are Chris LaVictoire Mahai’s holdings in HQH after this transaction?

Following the reported trade, Chris LaVictoire Mahai directly owns 501.0000 shares of abrdn Healthcare Investors. The Form 4 lists direct ownership (code “D”) for these Common Stock holdings, with no additional derivative securities reported in this filing’s summary.

Was the July 16, 2026 HQH stock purchase made under a Rule 10b5-1 trading plan?

The filing’s Rule 10b5-1 checkbox is unchecked, indicating the July 16, 2026 purchase was not made under a Rule 10b5-1 trading plan. No footnotes in the reported data suggest any pre-arranged trading arrangement for this specific transaction.

What transaction code and type are shown for the HQH insider trade?

The transaction is coded “P”, described as a “Purchase in open market or private transaction.” It is categorized as a non-derivative transaction in Common Stock, distinguishing it from option exercises, conversions, or other derivative-related activities sometimes seen in Form 4 filings.

Does this HQH Form 4 show any stock sales or derivative exercises by the director?

No stock sales or derivative exercises are reported; the filing shows only a single purchase of 501 shares. The transaction summary lists buyShares of 501, with sellShares and exerciseShares at 0, and no derivative positions in the derivative summary section.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mahai Chris LaVictoire

(Last)

(First)

(Middle)

C/O ABRDN

1900 MARKET STREET, SUITE 200

(Street)

PHILADELPHIA

PENNSYLVANIA

19103

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
abrdn Healthcare Investors [ HQH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	07/16/2026		P		501	A	$20.96	501	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

	/s/ Robert Stieger, by POA from Reporting Person	07/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR